Stock picks with research | support | resistance and technical analysis for trading | Day trading | stock investing in the market

• About US

Market Activity

Premium Plan

Trading Technologies

Day Trading

Stock Trading

Stock Trading Strategy

Technical Strategy

Breakout Stocks

Penny Stock investing

stock Breakout for day trading

Stock : AMED	\| Stock Recommendations : Buy
Sector : Healthcare	\| First resistance : 65.08
Stock Name : AMEDISYS INC COM	\| Second resistance : 67.29
Buy Near : 55.13	\| Third resistance :
StopLoss : 46.55	\| First Support : 55.03
Posted date : 11/2/2008 12:00:00 AM	\| Second Support : 46.55

Amedisys Inc. com (AMED) Stock has given a buy signal, with rising moving average. Stockhastic and ADX also given a buy signal.

Amedisys Inc. com (AMED) announced on 10/28/08 its profit grew 16 percent in the third quarter, and revenue jumped 78 percent. The company reported stronger admissions growth, and it was operating 150 more health agencies than a year earlier and also raised its full-year estimates, predicting greater profit and revenue Amedisys Inc. com (AMED) is a Home nursing company. As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. Amedisys Inc. com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to Stock market and economic condition keep tight stop loss on all position. You can buy this Stock near $55.13

Portfolio stock

Recent News Head Lines

Amedisys Completes Acquisition of AseraCare Hospice
(Mon, 01 Jun 2020 20:30:10 +0000)
Amedisys, Inc. (AMED), a leading provider of home health, hospice and personal care, announced today that, through one of its wholly owned subsidiaries, it has closed on its acquisition of Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice” or “AseraCare”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas. Under the terms of the agreement, Amedisys acquired 100 percent of the ownership interests in AseraCare Hospice for a cash purchase price of $235 million, which is inclusive of a $32 million tax asset bringing the net purchase price to $203 million.

Edited Transcript of AMED earnings conference call or presentation 7-May-20 3:00pm GMT
(Mon, 01 Jun 2020 20:29:54 +0000)
Q1 2020 Amedisys Inc Earnings Call

Amedisys to Present at the 2020 Jefferies Virtual Healthcare Conference
(Thu, 28 May 2020 20:30:10 +0000)
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 2020 Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

CEO Spins The Golden Rule Into Business Gold
(Thu, 28 May 2020 14:36:48 +0000)
Amedisys CEO Paul Kusserow doesn't try to lead. He aims to serve instead. And in the process he's built a winning company with heart.

12 health-care stocks that will be winners because of coronavirus-led trends, according to Jefferies
(Sat, 16 May 2020 16:51:00 +0000)
DEEP DIVE The COVID-19 pandemic has accelerated some health-care trends while opening people’s eyes to others that now seem obvious. Analysts at investment bank Jefferies have listed stocks of companies they argue are likely winners and losers from those trends.

Never go against major trend for day trading | stock trading

Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research

All Rights Reserved © 2000-2006 Flyingstock.com
Chart courtesy of StockCharts.com
Portfolio stock - AMEDISYS INC COM for Stock investing stock trading day trading

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.